Carbamazepine toxicity following Oxybutynin and Dantrolene administration: A case report

T. Vander*, H. Odi, V. Bluvstein, J. Ronen, A. Catz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Objective: To report a case of Carbamazepine toxicity following the administration of Oxybutynin and Dantrolene. Study design: A case report. Setting: The Spinal Rehabilitation Department, Loewenstein Hospital, Raanana, Israel. Methods: A patient with C6D tetraplegia who sustained intoxication because of drug interaction is presented. She had been treated by Carbamazepine 1000 mg/day for neuropathic pain for 2 years without clinical or laboratory signs of toxicity. After administration of Oxybutynin concomitantly with an increase in the dose of Dantrolene, she presented the clinical symptoms and laboratory finding of Carbamazepine intoxication. Trying to adjust the treatment to the patient's requirements, Carbamazepine together with Oxybutynin and Dantrolene was readministrated in lower doses. Results: The combination of these drugs, even small doses, caused toxicity. Adding Dantrolene and Oxybutynin elevated the blood level of Carbamazepine, possibly by inhibition of cytochrome P450. Conclusion: A possible pharmacokinetic interaction between Dantrolene and Oxybutynin should be borne in mind when considering Carbamazepine medication for a patient with a spinal cord lesion.

Original languageEnglish
Pages (from-to)252-255
Number of pages4
JournalSpinal Cord
Issue number4
StatePublished - Apr 2005


  • Carbamazepine
  • Cytochrome P450
  • Dantrolene
  • Drug interaction
  • Oxybutynin


Dive into the research topics of 'Carbamazepine toxicity following Oxybutynin and Dantrolene administration: A case report'. Together they form a unique fingerprint.

Cite this